[1]JournalofMedicinalChemistry,1993,vol.36,p.572-579
[2]Patent:US2017/114085,2017,A1.Locationinpatent:Paragraph0054
[3]Tetrahedron,2001,vol.57,p.4507-4522
[4]EuropeanJournalofMedicinalChemistry,2020,vol.186
[5]TetrahedronLetters,2020,vol.61
[6]JournalofOrganicChemistry,1959,vol.24,p.1042
[7]JournaloftheChemicalSociety,1952,p.4406,4408
[8]BioorganicandMedicinalChemistryLetters,2005,vol.15,p.4790-4793
[9]TetrahedronLetters,2006,vol.47,p.6899-6902
[10]GreenChemistry,2013,vol.15,p.798-810
[11]AngewandteChemie-InternationalEdition,2018,vol.57,p.16464-16468 Angew.Chem.,2018,vol.130,p.16702-16706,5
[1]TetrahedronLetters,2006,vol.47,p.6899-6902
[2]JournaloftheChemicalSociety,1952,p.4406,4408
[3]JournaloftheChemicalSociety,1952,p.4406,4408
[1]Patent:US5149700,1992,A
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101